Thursday - April 25, 2024

Category Archives: Financial Market

Hyperkalaemia Market Gearing Up for Outstanding Expansion During the Forecast Period (2023-32) | AstraZeneca, Ardelyx, Vifor Pharma, Zeria Pharmaceutical

Delveinsight Business Research LLP Hyperkalaemia Market size in the seven major markets was approximately USD 1,198 million in 2021, which is further expected to increase by 2032. As per DelveInsight, the Hyperkalaemia Market is anticipated to evolve immensely in the … Continue reading →

Non-Hodgkin’s Lymphoma Market Poised for Extraordinary Growth During the Forecast Period (2023-32), Asserts DelveInsight | AbbVie, Angiocrine, AstraZeneca, Autolus, Genmab, Loxo Oncology, Novartis

Delveinsight Business Research LLP As per DelveInsight, the Non-Hodgkin’s Lymphoma Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases of Non-Hodgkin’s Lymphoma and the launch of new therapies in the … Continue reading →

Systemic Lupus Erythematosus Market Anticipating Remarkable Growth by 2032, Insights by DelveInsight | Key Companies – AbbVie, Akeso, Amgen, Antengene, Biogen, Janssen, Citryll BV, Corestem, Medsenic

Delveinsight Business Research LLP As per DelveInsight, the Systemic Lupus Erythematosus Market is anticipated to evolve immensely in the coming years owing to the expected launch of emerging therapies and the rise in the number of cases of Systemic Lupus … Continue reading →

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Anticipating Remarkable Growth by 2032, Insights by DelveInsight | Eidos Therapeutics, NeuraImmune Therapeutics

Delveinsight Business Research LLP As per DelveInsight, the Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market is anticipated to evolve immensely in the coming years owing to the increasing prevalent population of transthyretin amyloid cardiomyopathy patients in the 7MM and the expected entry … Continue reading →

Osteoporosis Market Poised for Phenomenal Expansion During the Forecast Period (2023-32) – Estimates DelveInsight | Transcenta Holding, Celltrion, Sandoz, Samsung Bioepis, Alvotech, MAbxience

Delveinsight Business Research LLP As per DelveInsight, the Osteoporosis Market is anticipated to evolve immensely in the coming years owing to the rise in the number of prevalent cases of Osteoporosis in the 7MM and the launch of new therapies … Continue reading →

Burns Market Set to Experience Unprecedented Growth During the Forecast Period (2023-32) – Asserts DelveInsight | MediWound, Kaken Pharma, Kerecis, Mallinckrodt, Avita Medical, KeraNetics, PolyNovo

Delveinsight Business Research LLP The Burns Market is set to show an extensive jump by the end of 2032 and is anticipated to grow at a CAGR of 1.99% during the study period (2019–2032) in the 7MM. The Burns Market … Continue reading →

Multiple Sclerosis Market: Latest Study by DelveInsight Forecasts Remarkable Growth During the Forecast Period (2023-32) | Immunic, ANOKION, Merck Serono, CinnaGen, GeNeuro, Sanofi, Biogen, RemeGen

Delveinsight Business Research LLP The Multiple Sclerosis Market size in the seven major markets was found to be USD 22,381 million in 2020, which is expected to grow by 2032. As per DelveInsight, the Multiple Sclerosis Market is anticipated to … Continue reading →

Non-Muscle Invasive Bladder Cancer (NMIBC) Market: Latest Study by DelveInsight Reveals a Lucrative Investment Opportunity and Growth Prospect | Abraxis, Asieris, AstraZeneca, CG Oncolgy, ImmunityBio

Delveinsight Business Research LLP As per DelveInsight, the Non-Muscle Invasive Bladder Cancer Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases of NMIBC in the 7MM and the launch of … Continue reading →

Thrombocytopenia Market to Expand at a Significant Growth Rate During the Forecast Period (2023-32) – Asserts DelveInsight | Sanofi, Baxalta, Takeda, Argenx, GC Pharma, Genosco, Amgen, Novartis

Delveinsight Business Research LLP The Thrombocytopenia market size in the 7MM was observed to be USD 4,412 million in 2021, and it is expected to grow at a significant rate in the upcoming years. As per DelveInsight, the Thrombocytopenia Market … Continue reading →

Soft Tissue Sarcoma Market: Breakthrough Forecast Study Predicts Astounding Growth in the Upcoming Years | Philogen, Gradalis, Epizyme, CytRx, KaryoPharm, Nanobiotix, Apexigen, Lytix, Incyte, Iovance

Delveinsight Business Research LLP As per DelveInsight, the Soft Tissue Sarcoma Market is anticipated to evolve immensely in the coming years owing to the extensive research and development activities of pharmaceutical companies, along with the launch of various therapies, and … Continue reading →